Optegra Polskasp. z o.o.

Hospital activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-03-29
Share capital
11,250,000.00 PLN
Activity description

Optegra Polska operates ophthalmology clinics in nine of Poland’s largest cities as part of an international network also active in the Czech Republic, Slovakia and the United Kingdom. Its clinics provide laser vision correction, presbyopia correction and cataract surgery, as well as diagnosis and treatment of eye conditions, including retinal diseases and glaucoma.

Registered address
Bitwy Warszawskiej 1920 R. 18, 02-366 Warszawa, Poland
Opening hours
Monday–Friday
8:00–20:00
Phone
Social media
Electronic delivery address
AE:PL-44023-81406-GBHVF-18

Financials

Revenue history (in m)

Filing timeliness

1 of 6 financial statements was filed late (for 2022, 40 days late). All were audited by a statutory auditor.

  • 202530/06/2026
  • 202401/07/2025
  • 202302/07/2024
  • 202224/08/2023
  • 202112/01/2022
  • 202030/12/2020
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 39.37mMedianUSD 3.20mAverageUSD 13.50m
Net profit
This companyUSD 5.96mMedianUSD 60.50kAverageUSD 247.00k
Operating costs
This companyUSD 31.49mMedianUSD 2.95mAverageUSD 12.85m
Assets
This companyUSD 30.95mMedianUSD 2.20mAverageUSD 10.94m

Offer

  • Laser vision correction
  • Cataract surgery
  • Glaucoma treatment
  • Retinal disease treatment
  • Paediatric ophthalmology
  • Oculoplasty

Website technology

Website
  • WordPress
Contact and booking
  • ZnanyLekarz
Analytics and marketing
  • Google Tag Manager

National Health Fund (NFZ) contracts

Optegra Polska has been an NFZ healthcare provider since 2008. In 2026 it is performing 10 contracts with a total value of USD 5.23m. All its contracts were worth USD 38.58m in total.

NFZ contract value by year (in k USD)

Type of careNFZ branchContractsValue in 2026
Inpatient treatmentwielkopolskie2USD 1.96m
Inpatient treatmentdolnośląskie3USD 1.85m
Outpatient specialist carewielkopolskie2USD 732.83k
Outpatient specialist caredolnośląskie1USD 345.16k
Outpatient specialist caremazowieckie1USD 252.58k

NFZ waiting lists

This company's facilities run 14 NFZ waiting lists. Waiting time forecast by NFZ, as of 27.10.2026.

ServiceWaiting time
Treatment of patients with retinal diseases (AMD, DME)no wait
Treatment of patients with retinal diseases (AMD, DME)no wait
Glaucoma and cataract surgeryno wait
Treatment of patients with retinal diseases (AMD, DME)1 day
Treatment of patients with retinal diseases (AMD, DME)6 days

Trademarks

Optegra Polska holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2019.

MarkNumberClassesStatusProtected until
CLEARVU(word)Z.49517444Protected Jan 24, 2029
MarkProtected until
CLEARVU(word)Jan 24, 2029

Authorized Representatives

Agnieszka Szpara – President of the Management Board
Giulia Mazza – Management Board Member
Paweł Zaremba – Management Board Member

Manner of representation

In the case of a multi-member management board, two members of the management board acting jointly are authorized to make declarations of will and sign on behalf of the company.

Supervisory board

Jerry Georg – Supervisory Board Member
Jolanta Oficjalska Młyńczak – Supervisory Board Member
Spencer Ola – Supervisory Board Member

Beneficial owners

Person

Subsidiaries

NameStake
100%

Bank accounts

Registered as a VAT taxpayer on 2003-12-31.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Change history

DateEvent
2016-10-11Share capital increase
2016-04-15Share capital increase
2016-03-01Share capital increase
2015-01-15Name change
2014-05-20Address change

FAQ

Last updated: 2026-10-02